{"title":"The impact of a multidisciplinary team evaluation on the diagnosis and management of acute and chronic pancreatitis in a tertiary referral center.","authors":"Gaetano Lauri, Matteo Tacelli, Gabriele Capurso","doi":"10.1080/17474124.2026.2629615","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Multidisciplinary team meetings (MTM) are crucial in benign conditions such as acute pancreatitis (AP) and chronic pancreatitis (CP). Our aim was to evaluate the impact of MTM on the diagnosis and management of AP and CP in a tertiary referral center.</p><p><strong>Research design and methods: </strong>This retrospective study analyzed 232 patients with AP/CP discussed with biweekly MTM (10/2020-06/2024). The patients were classified according to etiology or complication management, recording diagnostic and therapeutic outcomes over six months.</p><p><strong>Results: </strong>Of 536 referred patients, 232 were analyzed (142 AP, 90 CP). In AP subgroup, MTM revised etiology in 34.4% of cases and identified a cause in 45.5% of idiopathic AP. MTM also ensured successful management of AP complications in 100% of cases, including endoscopic or surgical interventions for pseudocysts and walled-off necrosis. In CP, the diagnosis was revised in 38.9%, with a cause identified in 45.5% of idiopathic cases. MTM effectively guided CP complication management, with 55% of cases managed surgically and 10% endoscopically. MTM identified 6 cases of low-grade pancreatic intraepithelial neoplasia and 9 previously undiagnosed pancreatic ductal adenocarcinomas (PDAC) across both cohorts.</p><p><strong>Conclusions: </strong>In high-volume centers, MTM enhance diagnostic accuracy and optimize the tailored management of benign pancreatic diseases.</p>","PeriodicalId":12257,"journal":{"name":"Expert Review of Gastroenterology & Hepatology","volume":" ","pages":"191-199"},"PeriodicalIF":2.5000,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Gastroenterology & Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/17474124.2026.2629615","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/2/23 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Multidisciplinary team meetings (MTM) are crucial in benign conditions such as acute pancreatitis (AP) and chronic pancreatitis (CP). Our aim was to evaluate the impact of MTM on the diagnosis and management of AP and CP in a tertiary referral center.
Research design and methods: This retrospective study analyzed 232 patients with AP/CP discussed with biweekly MTM (10/2020-06/2024). The patients were classified according to etiology or complication management, recording diagnostic and therapeutic outcomes over six months.
Results: Of 536 referred patients, 232 were analyzed (142 AP, 90 CP). In AP subgroup, MTM revised etiology in 34.4% of cases and identified a cause in 45.5% of idiopathic AP. MTM also ensured successful management of AP complications in 100% of cases, including endoscopic or surgical interventions for pseudocysts and walled-off necrosis. In CP, the diagnosis was revised in 38.9%, with a cause identified in 45.5% of idiopathic cases. MTM effectively guided CP complication management, with 55% of cases managed surgically and 10% endoscopically. MTM identified 6 cases of low-grade pancreatic intraepithelial neoplasia and 9 previously undiagnosed pancreatic ductal adenocarcinomas (PDAC) across both cohorts.
Conclusions: In high-volume centers, MTM enhance diagnostic accuracy and optimize the tailored management of benign pancreatic diseases.
期刊介绍:
The enormous health and economic burden of gastrointestinal disease worldwide warrants a sharp focus on the etiology, epidemiology, prevention, diagnosis, treatment and development of new therapies. By the end of the last century we had seen enormous advances, both in technologies to visualize disease and in curative therapies in areas such as gastric ulcer, with the advent first of the H2-antagonists and then the proton pump inhibitors - clear examples of how advances in medicine can massively benefit the patient. Nevertheless, specialists face ongoing challenges from a wide array of diseases of diverse etiology.